AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
4DMedical Showcases Lung Imaging Advancements to U.S. Congress
April 10, 2025 03:30 PM AEST| By Team Kalkine MediaHighlights,4DMedical presented its advanced lung imaging technology to the U.S. Congress through a collaboration with Philips.,The company’s cardiopulmonary software transforms standard CT scans into detailed four-dimensional lung models.,Additional...
Shopify Adopts AI-First Policy Before Approving Workforce Expansion
April 10, 2025 03:16 PM AEST| By Team Kalkine MediaHighlights,Shopify mandates teams to prove tasks cannot be completed by AI before requesting additional hires,CEO emphasizes integrating autonomous AI agents into workflows across departments,Australia remains Shopify’s third-largest market with wide...
Orthocell Expands Asia-Pacific Strategy with Hong Kong Submission for Remplir™
April 10, 2025 03:13 PM AEST| By Team Kalkine MediaHighlights,Orthocell Ltd (ASX:OCC) has submitted a regulatory application in Hong Kong for its nerve repair product Remplir™,The company is expanding across Asia-Pacific following commercial traction in Australia, New Zealand, and Singapore,Orthocell...
Imugene Ltd Schedules Corporate Webinar to Outline Strategic Developments in Biotech Sector
April 10, 2025 03:06 PM AEST| By Team Kalkine MediaHighlights:,Imugene Ltd to host a live corporate webinar on April 16,Presentation will cover company updates and pre-submitted shareholder questions,Executive team including CEO and COO will lead the discussion,Imugene Ltd (ASX:IMU, OTC:IUGNF), a bio...
Tryp Therapeutics Initiates World-First Psilocin Trial for Binge Eating Disorder with Swinburne University
April 10, 2025 02:54 PM AEST| By Team Kalkine MediaHighlights,Tryp Therapeutics Ltd (ASX:TYP, OTC:TYPTF) collaborates with Swinburne University for a pioneering trial addressing Binge Eating Disorder,The study will utilise TRP-8803, a proprietary psilocin formulation, alongside psychotherapy,The tria...
Recce Pharmaceuticals Advances Phase III Trials with New Funding Initiatives
April 10, 2025 02:51 PM AEST| By Team Kalkine MediaHighlights:,Recce secures a cornerstone commitment from a private party alongside launching a new pro-rata entitlement offer,Funds to support two Phase III topical clinical trials in Indonesia and Australia,Company forecasts a strengthened cash posit...
Opthea (ASX:OPT) Initiates Cost-Cutting Measures Following Clinical Trial Setback
April 10, 2025 12:57 PM AEST| By Team Kalkine MediaHighlights,Opthea,(OPT) ends development of,sozinibercept,after trial,misses,endpoints.,Announces workforce reduction by 65% to manage finances.,Continues discussions with investors to navigate future strategies.,In a recent business update, Opthea (...
Revolutionizing Respiratory Health: 4DMedical (ASX:4DX) Achieves New Milestones
April 10, 2025 12:43 PM AEST| By Team Kalkine MediaHighlights,4DMedical (4DX) secures contracts enhancing stem cell therapy and lung implant trials.,Recognized in U.S. Congressional testimony for advancing veteran care.,CEO Andreas,Fouras,emphasizes the impact of their technology on treatment innovat...
Orthocell Broadens Asian Presence: Targets Hong Kong for Key Expansion
April 10, 2025 12:18 PM AEST| By Team Kalkine MediaHighlights,Orthocell,Ltd (OCC) steps into Hong Kong, aiming for a Q4 2025 launch.,Remplir,™,,Orthocell's,nerve repair product, aims for a 20% share in a US,$3.2 billion,market.,Recent successes in Singapore pave the way for further Asia-Pacific marke...
Opthea Restructures Strategy Following Clinical Trial Setbacks
April 10, 2025 11:30 AM AEST| By Team Kalkine MediaHighlights,Opthea discontinues late-stage clinical studies after failing to meet drug efficacy benchmarks,Significant workforce downsizing initiated to realign operations and preserve resources,Company engages in discussions with backers while tradin...
Melanie Farris Joins (ASX:PTX) Prescient Therapeutics Board to Enhance Governance and Strategy
April 10, 2025 11:24 AM AEST| By Team Kalkine MediaHighlights,Melanie Farris,appointed,as non-executive director at Prescient Therapeutics.,Farris to spearhead audit and risk committee, bolstering board oversight.,(PTX) Prescient continues to advance its precision oncology trials.,Prescient Therapeut...
Expanding Horizons: Osteopore (ASX:OSX) Gains European Approval for Custom Implants
April 09, 2025 03:51 PM AEST| By Team Kalkine MediaHighlights,Osteopore (OSX) receives European approval for specialized implants.,Projected growth driven by demand in cranial and orthopaedic markets.,Exclusive distribution partnership established with Zimmer Biomet.,Osteopore (ASX:OSX), a pioneer in...
Expanding Horizons: Osteopore Gains Vital EU Approval for Custom Implants
April 09, 2025 03:39 PM AEST| By Team Kalkine MediaHighlights,Osteopore (OSX) receives critical EU MDR approval for its tailored implants.,The approval paves the way for growth in the European custom implant markets.,Strategic partnership opportunities, including with Zimmer Biomet, are set to expand...
Unveiling Sonic Healthcare's Financial Landscape in 2025: A Comprehensive Overview
April 09, 2025 02:23 PM AEST| By Team Kalkine MediaHighlights,SHL's revenue shows steady growth with a modest CAGR of 0.8% over the last three years.,Sonic Healthcare (SHL) experiences a significant shift in profitability and debt management.,Current valuation suggests SHL shares may be trading below...
Biotech stocks that withstood the challenges of April 2 are now facing the pressure of Trump's latest pharmaceutical threat.
April 09, 2025 01:30 PM AEST| By Team Kalkine MediaHighlights:,CSL Ltd (ASX:CSL), Mesoblast (ASX:MSB), and Cochlear Ltd (ASX:COH) have seen shifts in share performance following tariff-related developments.,The healthcare sector emerged as the worst performer on the ASX 200 after renewed uncertainty...
Market Impact: New U.S. Tariffs to Affect Pharmaceutical Sector
April 09, 2025 12:56 PM AEST| By Team Kalkine MediaHighlights,President Trump announces new tariffs on pharmaceuticals.,(CSL) shares fall following tariff news.,U.S. trade policies could reshape global pharmaceutical trade dynamics.,In a recent development that could significantly impact the pharmace...
Orthocell Gains Ground: Brazilian Market Entry to Boost Global Presence
April 09, 2025 12:55 PM AEST| By Team Kalkine MediaHighlights,Orthocell,(OCC) approved for Striate+ in Brazil.,Strategic entry into a $65 million market.,Planned expansion across Latin America.,Orthocell (ASX:OCC), an innovator in regenerative medicine, has successfully obtained regulatory approval f...
Transurban Group's (ASX:TCL) Steady Climb: A Look at Its Current Position and Future Prospects
April 09, 2025 12:48 PM AEST| By Team Kalkine MediaHighlights,(TCL) has,witnessed,a 1.0% rise since the beginning of 2025.,Offers a compelling dividend yield of 4.57%, higher than its 5-year average.,Positioned to,benefit,from consistent government infrastructure spending and population growth.,Trans...
Insider Confidence in Amplia Therapeutics Despite Market Fluctuations
April 09, 2025 11:47 AM AEST| By Team Kalkine MediaHighlights,Significant insider purchases reflect confidence in (ATX).,Recent,market value decline challenges,initial,optimism.,Insider ownership suggests long-term commitment to company growth.,Over the past year, insiders of Amplia Therapeutics Limi...
Pro Medicus (ASX:PME) Gains Momentum Amid Market Volatility: Analyst Upgrade Highlights
April 08, 2025 03:16 PM AEST| By Team Kalkine MediaHighlights,Pro Medicus receives upgrade to overweight status.,Shares bounce back with a 6% increase.,Unchanged price target reflects ongoing confidence.,In a recent market update, Pro Medicus (ASX:PME), a leading health imaging software provider, has...
Advertise your brand on Kalkine Media